Biosimilars Market: By Product (Recombinant Non-Glycosylated Protein, Recombinant Glycosated Proteins, Peptides) By Technology (Monoclonal Antibodies Technology, Nuclear Magnetic Resonance Technology, Recombinant DNA Technology, Chromatography, Mass Spectroscopy, Electrophoresis, Western Blotting, Bioassay) By Application (Blood disorders, Oncology Diseases, Chronic and autoimmune diseases, Growth hormone deficiency, Multimodal Nonlinear Optical (NLO) Imaging) – Forecast (2015-2020).

Date: 2016-01

“BioSimilar is a bio pharmaceutical drug that have similar property to the drug previously licensed. As the number of diseased people increase, the demand for cheaper drugs also increase leading to increase in biosimilars market.

The global market for the biosimilars is segmented into different product types by technology and application. Each of these segmentations has been further broken down into the sub segments to give an in-depth and comprehensive analysis of biosimilars market

Regulations for biosimilars play a vital role as they maintain a balance between original & biosimilar products. Currently the geographic biosimilar market is segmented into Americas, Europe, APAC and rest of the world.

Some of the key players included in the report are:
Novaritis (Sandoz)
Glaxo Smith Kline

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample